Moderna MRNA

Health care sectorNasdaq

Close: $202.87; 09/29 close
Day change: +2.8%; vs previous close
Volume: 637,991; −25.3% vs 30-day average
52-week range: $22.32$208.72
1-year return: +700.9%; vs the close a year ago
Market cap: $81B; 399,235,889 shares · reported 07/24

Company

Exchange: Nasdaq
Sector: Health care
Industry: Biological Products, (No Diagnostic Substances)
Headquarters: Cambridge, Massachusetts
Fiscal year end: 12/31
Next earnings: 10/16, estimated

Members of Congress reported 2 trades in Moderna MRNA in the past 90 days (1 purchase, 1 sale).

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: 2; Last 90 days · 1 buys · 1 sales
Insider net buying: No record; Last 90 days · 0 buys · 0 sales
Next earnings: 10/16; Estimated from the last four quarters

Price

$202.87Day +2.8%1 year +700.9%

26-week trading

Common questions

Which members of Congress traded Moderna MRNA recently?: The latest reported trades: Rep. Maria Salazar, partial sale on 08/19 (reported 09/09) and Rep. Maria Salazar, purchase on 08/19 (reported 09/09).